Liechtenstein Pharmaceutical and Medical Goods Expenditure Share
Liechtenstein Pharmaceutical and Medical Goods Expenditure Share published by Eurostat, covering Liechtenstein at annual frequency (2005–2023).
Liechtenstein (2023)
12.2
% of current health expenditure
+0.5pp YoY
YoY Change
+0.5pp
percentage points
Trend
up
Series length
11
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2023 | 12.2 | +0.5pp |
| 2022 | 11.7 | +0.3pp |
| 2021 | 11.4 | -0.2pp |
| 2020 | 11.6 | +0.5pp |
| 2019 | 11.1 | -1.1pp |
| 2018 | 12.2 | +0.1pp |
| 2017 | 12.1 | -0.2pp |
| 2016 | 12.2 | +0.0pp |
| 2015 | 12.2 | +0.3pp |
| 2014 | 11.9 | +0.1pp |
| 2013 | 11.8 | n/a |
About this Dataset
Liechtenstein recorded 12.2 % of current health expenditure in 2023. The most recent year-on-year change was +0.5pp. The historical series (2005–2023) shows a peak of 12.2 in 2016 and a trough of 11.1 in 2019.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology ensuring cross-country comparability within the European statistical framework.
The chart above shows the full historical trend; the table below lists annual values with year-on-year changes.
Frequently Asked Questions
This indicator tracks liechtenstein pharmaceutical and medical goods expenditure share in Liechtenstein, published by Eurostat. Data covers 2005–2023 at annual frequency using harmonised methodology.
The most recent observation covers 2023. Eurostat typically publishes this series with a lag of several months after the reference period. Data is updated annual.
The series peaked at 12.2 % of current health expenditure in 2016 and reached its lowest recorded value of 11.1 in 2019. The latest reading of 12.2 in 2023 represents a year-on-year change of +0.5pp.